Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days 1.22€ 1.22€ Friday, 22nd Dec 2023 PHGN.F stock ended at 1.22€. During the day the stock fluctuated 0% from a day low at 1.22€ to a day high of 1.22€.
90 days 1.20€ 1.22€
52 weeks 0.92€ 1.48€

Historical Pharming Group N.V. prices

Date Open High Low Close Volume
Sep 08, 2023 1.18€ 1.18€ 1.18€ 1.18€ 0
Sep 07, 2023 1.14€ 1.14€ 1.14€ 1.14€ 0
Sep 06, 2023 1.17€ 1.17€ 1.17€ 1.17€ 0
Sep 05, 2023 1.17€ 1.17€ 1.17€ 1.17€ 0
Sep 04, 2023 1.18€ 1.18€ 1.18€ 1.18€ 0
Sep 01, 2023 1.17€ 1.17€ 1.17€ 1.17€ 0
Aug 31, 2023 1.19€ 1.19€ 1.19€ 1.19€ 0
Aug 30, 2023 1.18€ 1.18€ 1.18€ 1.18€ 0
Aug 29, 2023 1.17€ 1.17€ 1.17€ 1.17€ 0
Aug 28, 2023 1.17€ 1.17€ 1.17€ 1.17€ 0
Aug 25, 2023 1.18€ 1.18€ 1.18€ 1.18€ 0
Aug 24, 2023 1.21€ 1.21€ 1.21€ 1.21€ 0
Aug 23, 2023 1.18€ 1.18€ 1.18€ 1.18€ 0
Aug 22, 2023 1.14€ 1.14€ 1.14€ 1.14€ 0
Aug 21, 2023 1.10€ 1.10€ 1.10€ 1.10€ 0
Aug 18, 2023 1.10€ 1.10€ 1.10€ 1.10€ 0
Aug 17, 2023 1.11€ 1.11€ 1.11€ 1.11€ 0
Aug 16, 2023 1.09€ 1.09€ 1.09€ 1.09€ 0
Aug 15, 2023 1.11€ 1.11€ 1.11€ 1.11€ 0
Aug 14, 2023 1.10€ 1.10€ 1.10€ 1.10€ 0
Aug 11, 2023 1.13€ 1.13€ 1.13€ 1.13€ 0
Aug 10, 2023 1.12€ 1.12€ 1.12€ 1.12€ 11 061
Aug 09, 2023 1.13€ 1.13€ 1.13€ 1.13€ 0
Aug 08, 2023 1.10€ 1.10€ 1.10€ 1.10€ 0
Aug 07, 2023 1.14€ 1.14€ 1.14€ 1.14€ 0
Click to get the best stock tips daily for free!

About Pharming Group N.V.

Pharming Group N.V. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment ... PHGN.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT